MedTrace Logo

Prevention of Hernia After Loop Ileostomy Reversal

NCT03720262 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2025-08-19

No results posted yet for this study

Summary

PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.

Conditions

  • Loop Ileostomy

Interventions

COMBINATION_PRODUCT

Mesh reinforcement

Reinforcement of the abdominal wall with Ultrapro Advanced.

OTHER

No reinforcement

Suturing the abdominal wall without mesh reinforcement

Sponsors & Collaborators

Principal Investigators

  • Åsa Hallqvist Everhov, MS, PhD · Stockholm South General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2026-12-31
Completion
2029-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03720262 on ClinicalTrials.gov